Bill Text: TX HB82 | 2021-2022 | 87th Legislature | Introduced
Bill Title: Relating to pricing of and health benefit plan cost-sharing requirements for prescription insulin.
Spectrum: Bipartisan Bill
Status: (Introduced - Dead) 2021-02-25 - Referred to Insurance [HB82 Detail]
Download: Texas-2021-HB82-Introduced.html
87R1857 SMT-F | ||
By: Lucio III | H.B. No. 82 |
|
||
|
||
relating to pricing of and health benefit plan cost-sharing | ||
requirements for prescription insulin. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Chapter 1358, Insurance Code, is amended by | ||
adding Subchapter C to read as follows: | ||
SUBCHAPTER C. COST-SHARING LIMIT | ||
Sec. 1358.101. APPLICABILITY OF SUBCHAPTER. (a) This | ||
subchapter applies only to a health benefit plan that provides | ||
benefits for medical or surgical expenses incurred as a result of a | ||
health condition, accident, or sickness, including an individual, | ||
group, blanket, or franchise insurance policy or insurance | ||
agreement, a group hospital service contract, or a small or large | ||
employer group contract or similar coverage document that is | ||
offered by: | ||
(1) an insurance company; | ||
(2) a group hospital service corporation operating | ||
under Chapter 842; | ||
(3) a fraternal benefit society operating under | ||
Chapter 885; | ||
(4) a stipulated premium company operating under | ||
Chapter 884; | ||
(5) a reciprocal exchange operating under Chapter 942; | ||
(6) a health maintenance organization operating under | ||
Chapter 843; | ||
(7) a multiple employer welfare arrangement that holds | ||
a certificate of authority under Chapter 846; or | ||
(8) an approved nonprofit health corporation that | ||
holds a certificate of authority under Chapter 844. | ||
(b) This subchapter applies to group health coverage made | ||
available by a school district in accordance with Section 22.004, | ||
Education Code. | ||
(c) Notwithstanding any provision in Chapter 1551, 1575, | ||
1579, or 1601 or any other law, this subchapter applies to: | ||
(1) a basic coverage plan under Chapter 1551; | ||
(2) a basic plan under Chapter 1575; | ||
(3) a primary care coverage plan under Chapter 1579; | ||
and | ||
(4) basic coverage under Chapter 1601. | ||
(d) Notwithstanding any other law, this subchapter applies | ||
to coverage under: | ||
(1) the child health plan program under Chapter 62, | ||
Health and Safety Code, or the health benefits plan for children | ||
under Chapter 63, Health and Safety Code; and | ||
(2) the medical assistance program under Chapter 32, | ||
Human Resources Code. | ||
Sec. 1358.102. EXCEPTION. This subchapter does not apply | ||
to: | ||
(1) a health benefit plan that provides coverage: | ||
(A) only for a specified disease or for another | ||
single benefit; | ||
(B) only for accidental death or dismemberment; | ||
(C) for wages or payments in lieu of wages for a | ||
period during which an employee is absent from work because of | ||
sickness or injury; | ||
(D) as a supplement to a liability insurance | ||
policy; | ||
(E) for credit insurance; | ||
(F) only for dental or vision care; | ||
(G) only for hospital expenses; or | ||
(H) only for indemnity for hospital confinement; | ||
(2) a Medicare supplemental policy as defined by | ||
Section 1882(g)(1), Social Security Act (42 U.S.C. Section 1395ss); | ||
(3) medical payment insurance coverage provided under | ||
a motor vehicle insurance policy; | ||
(4) a long-term care insurance policy, including a | ||
nursing home fixed indemnity policy, unless the commissioner | ||
determines that the policy provides benefit coverage so | ||
comprehensive that the policy is a health benefit plan as described | ||
by Section 1358.101; | ||
(5) health and accident coverage provided by a risk | ||
pool created under Chapter 172, Local Government Code; or | ||
(6) a workers' compensation insurance policy. | ||
Sec. 1358.103. LIMIT ON COST-SHARING REQUIREMENT. (a) In | ||
this section, "insulin" means a prescription drug that contains | ||
insulin and is used to treat diabetes. The term does not include an | ||
insulin drug that is administered to a patient intravenously. | ||
(b) A health benefit plan may not impose a cost-sharing | ||
provision for insulin if the total amount the enrollee is required | ||
to pay exceeds $100 for a 30-day supply, regardless of the amount or | ||
type of insulin needed to fill the enrollee's prescription. | ||
SECTION 2. (a) In this section, "commission" means the | ||
Health and Human Services Commission. | ||
(b) The commission shall conduct a study evaluating pricing | ||
of prescription insulin drugs to ensure adequate consumer | ||
protections in pricing of prescription insulin drugs and consider | ||
whether additional consumer protections are necessary. | ||
(c) The commission shall request from health benefit plan | ||
issuers and prescription drug manufacturers information concerning | ||
the organization, business practices, pricing information, data, | ||
reports, or other information the commission determines is | ||
necessary to conduct the study. The commission shall also consider | ||
any publicly available information related to prescription insulin | ||
pricing. | ||
(d) A health benefit plan issuer or prescription drug | ||
manufacturer who receives a request from the commission under | ||
Subsection (c) of this section shall furnish the commission with | ||
the information as soon as practicable after the date the issuer or | ||
manufacturer receives the request. | ||
(e) The commission may not require a health benefit plan | ||
issuer or prescription drug manufacturer to disclose trade secrets | ||
in information provided to the commission under Subsection (d) of | ||
this section. | ||
(f) Not later than September 1, 2022, the commission shall | ||
prepare and submit to the governor, the lieutenant governor, and | ||
the speaker of the house of representatives a written report | ||
containing the results of the study. The report must include: | ||
(1) a summary of insulin pricing practices and | ||
variables that contribute to pricing of health benefit plans; | ||
(2) policy recommendations to control and prevent | ||
overpricing of prescription insulin; and | ||
(3) any other information the commission determines is | ||
necessary. | ||
(g) The commission shall publish the report described by | ||
Subsection (f) of this section on its Internet website. | ||
(h) This section expires September 1, 2023. | ||
SECTION 3. The changes in law made by this Act apply only to | ||
a health benefit plan that is delivered, issued for delivery, or | ||
renewed on or after January 1, 2022. A health benefit plan | ||
delivered, issued for delivery, or renewed before January 1, 2022, | ||
is governed by the law as it existed immediately before the | ||
effective date of this Act, and that law is continued in effect for | ||
that purpose. | ||
SECTION 4. This Act takes effect September 1, 2021. |